big_sugar_grain_brain

Reflecting on CBS This Morning

Wow! Yesterday, the release of Grain Brain Revised, was an incredibly exciting day. From visiting with the folks at MindBodyGreen to taking your questions live in numerous live chats on Facebook and Instagram, I was privileged to get to spend the day speaking with you all and spreading our message on optimal health.

But it goes without saying that the most provocative part of my day was how it started — my conversation with CBS This Morning. Let me start by saying it was an honor to get to sit with such a storied team of reporters. It was humbling to have Gayle, John, and the entire team present for this dialogue.

Continue reading

alzheimers_drugs

Alzheimer’s Drugs Worsen Cognitive Function

It’s becoming quite common these days to see news releases documenting the failure of yet another experimental drug for the treatment of Alzheimer’s disease. In fact, one major pharmaceutical company, Pfizer, indicated in February of this year that they were no longer going to pursue efforts to develop a drug to treat this disease, which is now reaching epidemic proportions.

That said, millions of Americans are already taking medication that is FDA approved, to “treat” their Alzheimer’s disease. Since these medications are FDA approved, one would expect that they’ve been extensively tested and proven not only safe, but effective as well. Continue reading

reversing_alzheimers_disease

Yes – Alzheimer’s Can be Reversed!

I’ve often been quoted as stating that there is no pharmaceutical approach that has meaningful effectiveness on the treatment of Alzheimer’s disease. Unfortunately, I have to continue to make this claim. As was recently reported in the journal Neurology:

Despite great scientific efforts to find treatments for Alzheimer’s disease (AD), only 5 medications are marketed, with limited beneficial effects on symptoms, on a limited proportion of patients, without modification of disease course. The prevalence of AD doubles every 5 years reaching an alarming rate of 50% in those aged 85 years and older. In the context of the demographic trends of modern society, where the elderly are the fastest growing segment of the population, identification of new therapeutic targets that may prevent, delay, or cure AD is critically needed. (italics added).

The authors reemphasize what we know: that there is no silver bullet available now, or in the foreseeable future, that will help with this devastating and fatal condition. Continue reading